Healthcare >> Analyst Interviews >> December 18, 2000

Outlook For Biotechnology Stocks: William Slattery – Deerfield Management

WILLIAM SLATTERY is a Partner at Deerfield Management Company covering the biotechnology and healthcare based Internet technologies. He began his career at the laboratory bench, studying complications associated with End Stage Renal Disease. Mr. Slattery was previously associated with Amerindo Investment Advisors, Inc., National Medicine Enterprises, Lifescan/Johnson & Johnson and HMSS, a division of Secomerica. He received a BSc degree in Biochemistry from the State University of New York at Albany and attended the Graduate School of Health at Rutgers. Profile
TWST: Bill, what has been driving the performance of the biotechnology

stocks in 2000?

Mr. Slattery: 2000's outstanding biotechnology stock performance has

been prompted in part by at least